Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07331740 | Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer Patients | not yet recruiting | N/A | 20 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT07317752 | Incidence of Dysgeusia in Breast Cancer Patients Undergoing Chemotherapy(GustiAmo) | not yet recruiting | — | 40 | Azienda Sanitaria Locale CN2 Alba-BraOTHER |
| 0 |
| Jan 5, 2026 |
| clinicaltrials |
| NCT07311122 | Endocrine Therapy Base on 21-gene RS(CUSTOM) | not yet recruiting | — | 4,000 | Gangnam Severance HospitalOTHER | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07307287 | SHR-A1811 Plus Pertuzumab as Neoadjuvant Therapy for Early or Locally Advanced HR-Positive HER2-Positive Breast Cancer: A Prospective, Open-Label, Phase II Study | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Dec 29, 2025 | clinicaltrials |
| NCT07305246 | Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer | not yet recruiting | Phase 2 | 120 | First Hospital of China Medical UniversityOTHER | 0 | Dec 26, 2025 | clinicaltrials |
| NCT07299409 | First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. | not yet recruiting | Phase 2 | 24 | Nathalie LevasseurOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT07299890 | An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer | not yet recruiting | Phase 2 | 90 | Anhui Provincial Cancer HospitalOTHER | 0 | Dec 23, 2025 | clinicaltrials |
| NCT07300215 | An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer | not yet recruiting | Phase 2 | 60 | The First Affiliated Hospital of Bengbu Medical UniversityOTHER | 0 | Dec 23, 2025 | clinicaltrials |
| NCT07238127 | AST/ALT & MPV/Platelets Ratios in Breast Cancer | not yet recruiting | — | 110 | Assiut UniversityOTHER | 0 | Dec 19, 2025 | clinicaltrials |
| NCT07290166 | A Phase II Study to Evaluate the Efficacy and Safety of Anti-HER2 Triple-targeted Drugs Combined With CDK4/6 Inhibitors in Neoadjuvant Therapy for ER-positive HER2-positive Breast Cancer Patients.(Cinderella-Neo) | not yet recruiting | Phase 2 | 42 | Fudan UniversityOTHER | 0 | Dec 18, 2025 | clinicaltrials |
| NCT07292142 | FMT in Triple Negative Breast Cancer Guided by ctDNA(FRIDA) | not yet recruiting | Phase 1 / Phase 2 | 125 | Jewish General HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07292207 | Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer(ARCHE) | not yet recruiting | Phase 2 | 30 | Nagoya City UniversityOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07292727 | Effect of Virtual Reality on Pain and Anxiety During Chemotherapy Session in Breast Cancer Patients | not yet recruiting | N/A | 50 | Cairo UniversityOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07286539 | Precision Physical Exercise for Personalized Onco-Hematology.(PEPOH) | not yet recruiting | N/A | 150 | University of SalamancaOTHER | 0 | Dec 16, 2025 | clinicaltrials |
| NCT05128734 | Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC) | not yet recruiting | Phase 2 | 40 | AHS Cancer Control AlbertaOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT07254221 | Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients(ROSUBREAST) | not yet recruiting | Phase 4 | 400 | Shiraz University of Medical SciencesOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT07271992 | TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer(TREND-02) | not yet recruiting | Phase 2 | 30 | First Hospital of China Medical UniversityOTHER | 0 | Dec 9, 2025 | clinicaltrials |
| NCT07269691 | RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer | not yet recruiting | Phase 3 | 194 | Pengfei QiuOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07267572 | Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer(AELO) | not yet recruiting | N/A | 66 | ElsanOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07268469 | Minimal Residual Disease in Solid Malignancies(IMRD) | not yet recruiting | N/A | 840 | European Institute of OncologyOTHER | 0 | Dec 5, 2025 | clinicaltrials |
| NCT06787118 | Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer(PANDORA) | not yet recruiting | Phase 3 | 130 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07257003 | A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After Simple Mastectomy(DEDTI-BR) | not yet recruiting | N/A | 150 | Du ZhengguiOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07259434 | Time Restricted Eating in Survivors Trial 2.0(TEST2) | not yet recruiting | N/A | 152 | University of TorontoOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07260058 | Immune Cell Therapy for Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 48 | Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.INDUSTRY | 0 | Dec 2, 2025 | clinicaltrials |
| NCT07255612 | Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer) | not yet recruiting | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT07246317 | Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer | not yet recruiting | Phase 2 | 188 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT07253168 | Tumor Integrating Gut Microbiota in bREast Cancer(TIGER-BC) | not yet recruiting | N/A | 240 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Nov 28, 2025 | clinicaltrials |
| NCT07244588 | Shaving as an Safe Alternative to Frozen Section Analysis | not yet recruiting | N/A | 30 | Mark Ezzat GergesOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07245316 | Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial(ASAIN) | not yet recruiting | N/A | 340 | Jeong Eon LeeOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07246720 | IPP-PSP Block vs. SPSIPB in Breast Surgery | not yet recruiting | N/A | 70 | Zonguldak Bulent Ecevit UniversityOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07246759 | Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis(NEUTROFLOW) | not yet recruiting | — | 600 | OncoHost Ltd.INDUSTRY | 3 | Nov 24, 2025 | clinicaltrials |
| NCT07243418 | Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study | not yet recruiting | Phase 2 | 72 | Fujian Cancer HospitalOTHER_GOV | 0 | Nov 21, 2025 | clinicaltrials |
| NCT07237828 | Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR(DRAIN) | not yet recruiting | N/A | 379 | Du ZhengguiOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07236359 | Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction(Reborn-i) | not yet recruiting | N/A | 108 | Beaumont HospitalOTHER | 0 | Nov 19, 2025 | clinicaltrials |
| NCT06873191 | A Study to Learn More About Tukysa Once it is Out in the Korean Market | not yet recruiting | — | 600 | PfizerINDUSTRY | 0 | Nov 17, 2025 | clinicaltrials |
| NCT07178938 | Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases(THERANOVA) | not yet recruiting | Phase 2 | 10 | MedSIROTHER | 0 | Nov 14, 2025 | clinicaltrials |
| NCT07213206 | CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer(Cinderella) | not yet recruiting | Phase 3 | 1,500 | Fudan UniversityOTHER | 0 | Oct 8, 2025 | clinicaltrials |
| NCT05832138 | ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario | not yet recruiting | N/A | 900 | The Hospital for Sick ChildrenOTHER | 0 | Oct 6, 2025 | clinicaltrials |
| NCT07198672 | Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag | not yet recruiting | N/A | 45 | Zhenzhen LiuOTHER_GOV | 0 | Sep 30, 2025 | clinicaltrials |
| NCT07197697 | A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients | not yet recruiting | Phase 2 | 30 | Anhui Provincial Cancer HospitalOTHER | 0 | Sep 29, 2025 | clinicaltrials |
| NCT07183813 | Acupuncture for Anxiety/Depression in Patients With Breast Cancer | not yet recruiting | N/A | 360 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07189884 | Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy | not yet recruiting | Phase 1 / Phase 2 | 33 | The First Affiliated Hospital of Xiamen UniversityOTHER | 0 | Sep 24, 2025 | clinicaltrials |
| NCT07190651 | Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy(VIRTUOSA) | not yet recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Sep 24, 2025 | clinicaltrials |
| NCT07187674 | The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel | not yet recruiting | N/A | 20 | Harbin Medical UniversityOTHER | 0 | Sep 23, 2025 | clinicaltrials |
| NCT07187752 | Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes | not yet recruiting | N/A | 1,039 | Shandong Cancer Hospital and InstituteOTHER | 0 | Sep 23, 2025 | clinicaltrials |
| NCT07188116 | Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer | not yet recruiting | — | 200 | Zhejiang HospitalOTHER | 1 | Sep 23, 2025 | clinicaltrials |
| NCT07184749 | Neurocognitive and Psychological Impact of Chemotherapy in Breast Cancer Patients: A Prospective Observational Study | not yet recruiting | — | 100 | Sohag UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07179939 | Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study | not yet recruiting | Phase 2 | 288 | Fudan UniversityOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07124403 | DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure(DESIR) | not yet recruiting | — | 742 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Sep 17, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 12, 2026source: clinicaltrials